NEW

MITA Urges Regulatory Changes to Get Mobile Imaging to Emergency COVID-19 Pandemic Hospitals

The Medical Imaging & Technology Alliance (MITA) today sent a letter to the Food and Drug Administration (FDA) outlining key steps the agency can take to help the medical imaging industry swiftly and thoroughly aid the response to the COVID-19 pandemic. Addressed...

FDA Shares Coronavirus (COVID-19) Update

The U.S. Food and Drug Administration today announced the following actions taken in its ongoing response effort to the COVID-19 pandemic: FDA-ARGOS SARS-CoV-2 Reference Grade Sequence Data Now Available: In response to the COVID-19 pandemic, the FDA—in collaboration...

FDA: MQSA Inspection Information Related to COVID-19

The Division of Mammography Quality Standards (DMQS) has received numerous inquiries regarding COVID-19 and its increasing impact on mammography facilities. The FDA has temporarily postponed domestic inspections including ones performed under contract with its state...

3M Outlines Latest Actions on COVID-19 Response

3M Chairman and CEO Mike Roman issued the following update announcing additional details about 3M’s capacity increases of N95 respirators, strong measures to combat price gouging and counterfeiting, and new partnerships to help protect our healthcare workers on the...

Mindray Launches New TE7 ACE Point-of-Care Solution

Mindray Medical has announced the release of a new point-of-care ultrasound system. The TE7 ACE is a new touch screen ultrasound system that provides targeted solutions to diverse point-of-care scenarios including: anesthesia, critical care and emergency.

Featuring smart fluid management tools, safe needling toolkit, seamless data connectivity and a complete disinfection solution, TE7 ACE helps clinicians to deal with diagnostic challenges and make rapid decision.

“Having identified the clinical challenges, Mindray developed this solution to empower clinicians with more confidence to focus on patient care,” said Xujin He, the general manager of medical imaging system business unit at Mindray.

In terms of managing patient body fluid, quick assessment can help to work out the fluid therapy plan and save lives. Based on deep learning algorithms, the clinically proven advanced fluid measurement tools of TE7 ACE are offered to accelerate patient assessments accurately and efficiently:

  • Smart VTI: automatically calculates the Velocity Time Integral, Cardiac Output and Stroke Volume Variation. The trending graph helps for efficient recording and guides for the fluid therapy.
  • Smart IVC: automatically traces the IVC diameter change, and calculates the Collapsibility Index or Distensibility Index and IVC Variation, helps for the assessment of volume status and responsiveness.
  • Smart B-line: automatically calculates B-lines number, percentage, and distance. It provides unique visual scoring map for intuitive overall lung water evaluation, guiding the fluid infusion and preventing pulmonary edema.

To ensure safe, simple and convenient needle guidance, the newly launched L12-3VNs with 3 programmable buttons combines eSpacial NaviTM and remote control into one so that clinicians can perform puncture without touching the system.

The connectivity solution eGateway also enables TE7 ACE to seamlessly fit into the existing hospital network, incorporating patient’s clinical data collected from both ultrasound equipment and patient monitors for wiser clinical decision making. This efficient and paperless process improves productivity while reducing the risk of transcription errors.

Previous

Next

Submit a Comment

Your email address will not be published. Required fields are marked *